152 results on '"Schwartz, Marc"'
Search Results
2. Mo1538: BASELINE PERIPHERAL BLOOD EOSINOPHILIA PREDICTS DECREASED RESPONSE TO INITIAL ANTI-TNF BIOLOGIC THERAPY IN IBD
3. Sa1587: GRANULOMA PRESENCE AT INITIAL SURGERY PREDICTS NEED FOR REPEAT SURGERY INDEPENDENT OF RUTGEERTS’ ENDOSCOPIC SCORE IN CROHN'S DISEASE
4. 1138: ULTRA-PROCESSED FOOD CONSUMPTION AND MULTIYEAR CLINICAL TRAJECTORIES IN IBD
5. Mo1832 PERIPHERAL BLOOD MONOCYTOSIS IS ASSOCIATED WITH INCREASED RISK OF INITIAL BIOLOGIC TREATMENT FAILURE IN IBD
6. Sa1939 APPLYING THE GLIM CRITERIA TO IDENTIFY IBD PATIENTS AT RISK FOR MALNUTRITION USING THE ELECTRONIC MEDICAL RECORD: A PRAGMATIC POPULATION HEALTH FEASIBILITY PILOT STUDY
7. 550 INTESTINAL ANASTOMOSIS TYPE IMPACTS 5 YEAR POST-OPERATIVE QUALITY OF LIFE AND NEED FOR REPEAT SURGERY IN CROHN'S DISEASE: A REAL WORLD COMPARATIVE EFFECTIVENESS STUDY.
8. Tu1645 DIFFERENTIAL PATTERNS AND BENEFIT OF IBS-D MEDICATION USE IN SURGICALLY NAIVE PATIENTS WITH CROHN'S DISEASE AND ULCERATIVE COLITIS
9. Mo1778 LOW SERUM LIPASE IS A BIOMARKER OF IMPENDING HOSPITALIZATION IN IBD: ASSOCIATION WITH MALNUTRITION AND CLINICAL INFLAMMATORY SEVERITY
10. Mo1824 CONCOMITANT VASCULITIS AND INFLAMMATORY BOWEL DISEASE DEFINES A RARE, SEVERE DISEASE SUBGROUP WITH HIGH BIOLOGIC REQUIREMENT
11. Su524 PERIPHERAL BLOOD MONOCYTOSIS IS A NOVEL BIOMARKER OF LONG-TERM DISEASE SEVERITY IN PEDIATRIC-ONSET INFLAMMATORY BOWEL DISEASE
12. Su507 INCREASED HOSPITAL ADMISSIONS ARE ASSOCIATED WITH DECREASED GUT MICROBIOME DIVERSITY AND DECREASED FAECALOBACTERIUM IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A PROSPECTIVE STUDY
13. Sa487 DERMATOLOGIC MANIFESTATIONS OF IBD: ASSOCIATION WITH NATURAL HISTORY AND BIOMARKERS OF SEVERITY
14. Su515 THE ASSOCIATION OF ORAL VANCOMYCIN ADMINISTRATION AND FAECAL MICROBIOME COMPOSITION IN PATIENTS WITH CROHN'S DISEASE
15. 249 POSITIVE GLUTEN SENSITIVITY SEROLOGIES AND THE IMPACT OF GLUTEN FREE DIET IN PATIENTS WITH IBD
16. EXPLORING THE REPRODUCTIVE HEALTH DECISION EXPERIENCES AND PREFERENCES OF WOMEN WITH INFLAMMATORY BOWEL DISEASES
17. Mo1808 THE EFFECTS OF ILEOCECAL RESECTION ON FECAL MICROBIOME DIVERSITY AND COMPOSITION ARE NOT SIGNIFICANTLY ALTERED BY BILE ACID SEQUESTRANTS IN PATIENTS WITH CROHN'S DISEASE
18. Sa1821 PREVALENCE AND RISK FACTORS OF EXOCRINE PANCREATIC INSUFFICIENCY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
19. Sa1858 DISPARITIES IN SOCIOECONOMIC STATUS AND HOUSEHOLD INCOME IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE ASSOCIATE WITH LESS HEALTHY DIETS AND DISEASE SEVERITY
20. Sa1975 INTERACTION OF SUGAR-SWEETENED BEVERAGE CONSUMPTION AND GENDER ON IBD MULTI-YEAR CLINICAL TRAJECTORIES: A PROSPECTIVE COHORT STUDY
21. Sa1885 PERIPHERAL BLOOD EOSINOPHILIA PREDICTS EARLIER ANTI-TNF CESSATION AND BIOLOGIC SWITCH IN ULCERATIVE COLITIS PATIENTS: A COHORT ANALYSIS
22. 25 ASSOCIATION OF ADDED DIETARY SUGAR AND WORSE MENTAL HEALTH STATUS IN INFLAMMATORY BOWEL DISEASE
23. Sa1979 STABILITY OF DIETARY PATTERNS IN INFLAMMATORY BOWEL DISEASE PATIENTS OVER A MULTIYEAR PERIOD USING A FOOD FREQUENCY QUESTIONNAIRE
24. 349 MULTIYEAR COMPARISON OF INFLUENCE OF ANTI-SACCHAROMYCES CEREVISIAE ANTIBODIES ON INFLAMMATORY BOWEL DISEASE SEVERITY
25. Sa1823 DO ESTROGEN CONTRACEPTIVES WORSEN DISEASE SEVERITY OR QUALITY OF LIFE IN FEMALE PATIENTS WITH INFLAMMATORY BOWEL DISEASE? A MULTI-YEAR NATURAL HISTORY STUDY
26. 403 THE IMPACT OF CHOLECYSTECTOMY ON LONG-TERM DISEASE OUTCOMES AND QUALITY OF LIFE IN PATIENTS WITH CROHN'S DISEASE
27. Mo1823 BURDEN OF NEPHROLITHIASIS IN INFLAMMATORY BOWEL DISEASE: ASSOCIATION WITH DISEASE SEVERITY AND DIETARY PATTERNS
28. Su1195 DIFFERENTIAL ANTIBIOTIC AND ANTI-FUNGAL TREATMENT REQUIREMENTS AND MULTIYEAR DISEASE SEVERITY IN IBD PATIENTS STRATIFIED BY ANTI-SACCHAROMYCES SEROLOGIC STATUS
29. P019 OPTIMIZING NUTRITION RISK SCREENING AND FOLLOW-UP NUTRITION COUNSELING IN AN OUTPATIENT INFLAMMATORY BOWEL DISEASE POPULATION
30. P006 AFTER-HOURS PATIENT PHONE CALLS TO GI FELLOWS WITHIN AN IBD MEDICAL HOME
31. Sa1764 – Peripheral Blood Eosinophilia is a Biomarker of Long-Term Severity in Pediatric-Onset Inflammatory Bowel Disease Patients
32. Sa1788 – Natural History of Diabetes Mellitus and Inflammatory Bowel Disease: Increased Disease Severity, Worse Quality of Life, and Under-Treatment with Immunomodulator And/Or Biologic Agents
33. Mo1856 – Big Data Analytics Identifies Ulcerative Colitis Patients At Increased Risk for Incident Colorectal Neoplasia Using Multiyear Patterns of Routine Clinical Lab Values
34. Su1782 – Reduction of Opioid Use and Depression Within an IBD Medical Home Care Model
35. Sa1821 – Does Inflammation in IBD “Burnout” Over Time?
36. Mo1893 – Peripheral Blood Eosinophilia Functions As a Candidate Biomarker of Decreased Response to Anti-TNF Therapy in Crohn’s Disease
37. Mo1823 – Endoscopic Patterns and Location of Post-Operative Recurrence in Crohn’s Disease Patients with Side to Side Anastomosis Following Ileocecal Resection
38. Su1890 - Finding the Sweet Spot: The Association Between Added Dietary Sugars and Inflammatory Bowel Disease Severity
39. Mo1829 - The Impact of Serum Cortisol on Quality of Life and Dysautonomia in Inflammatory Bowel Disease
40. Sa1812 - Does Surgical Anastamosis type Impact Rates of Endoscopic Recurrence in Post-Operative Crohn's Disease? An 8-Year Observational Cohort Study
41. Su1926 - Seven-Year Period Prevalence and Characteristics of Hypertension in a Large us Inflammatory Bowel Disease Cohort
42. Su1824 - Biomakers Associated with Early Endoscopic Recurrence of Postoperative Crohn's Disease
43. Tu1782 - Tofacitinib Reduces Inflammatory Biomarkers in Ex Vivo Intestinal Tissue from Patients with Ulcerative Colitis and Healthy Controls
44. Effects of Behavioral Treatment on Anxiety and Medical Utilization in Patients with IBD or FGID
45. Variation in Annual Rate of Steroid Prescriptions Amongst Providers for Inflammatory Bowel Disease Patients is Dependent on Cohort Size and Disease Severity
46. Is High Globulin Fraction a Biomarker of Severity in Inflammatory Bowel Disease (IBD)? Analysis of a 6-Year, Prospective Natural History Registry
47. Poor Consumption of Fiber, not fat, is Associated with Active Disease in Inflammatory Bowel Disease
48. 165 Is Monocytosis a Biomarker of Severity in Inflammatory Bowel Disease? Analysis of a 6 Year, Prospective Natural History Registry
49. 1123 Investigating the Changes in Atherosclerotic Cardiovascular Risk Profile of IBD Patients Over 6 Years
50. Tu1946 Can We Phenotype IBD Patients Based on Financial Charges Over Time? Trajectory Modeling of Healthcare Utilization in a Large, Prospective IBD Cohort
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.